Direct comparison of18F-fluorodeoxyglucose coincidence gamma camera tomography with gallium scanning for the staging of lymphoma
- 10 February 2005
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 35 (2), 91-96
- https://doi.org/10.1111/j.1445-5994.2004.00744.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphomaThe American Journal of Medicine, 2002
- The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatmentSeminars in Nuclear Medicine, 2001
- PET imaging using dual-headed gamma camerasNuclear Medicine Communications, 1999
- Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphomaNuclear Medicine Communications, 1998
- Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s diseaseAnnals of Oncology, 1998
- Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1998
- Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.Radiology, 1998
- Extranodal malignant lymphoma: detection with FDG PET versus CT.Radiology, 1998
- Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.Radiology, 1997
- The role of high dose 67‐gallium scintigraphy in staging untreated patients with lymphomaAustralian and New Zealand Journal of Medicine, 1994